SCHEMBL1453569

SCHEMBL1453569

C[CH]CCCCCNc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
MAPT P10636 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.42
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
KCNH3 Q9ULD8 2/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
ACHE P22303 2/20 0.38
BCHE P06276 1/20 0.38
PRSS1 P07477 4/20 0.38
F2 P00734 2/20 0.38
PRSS2 P07478 2/20 0.38
PRSS3 P35030 2/20 0.38
TMPRSS6 Q8IU80 2/20 0.38
ST14 Q9Y5Y6 2/20 0.38
SIGMAR1 Q99720 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1454056 1.00 ALDH1A1 (0.59) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL1454687 1.00 ALDH1A1 (0.59) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL1454849 1.00 ALDH1A1 (0.59) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL1454219 0.98 MAPT (0.61) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL1453819 0.92 MAPT (0.64) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL1454080 0.84 MAPT (0.56) ALDH1A1MAPTL3MBTL1CYP1A2CYP3A4
SCHEMBL14968385 0.83 ALDH1A1 (0.84) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL4104788 0.83 ALDH1A1 (0.84) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL11759173 0.83 ALDH1A1 (0.84) ALDH1A1MAPTL3MBTL1HDAC3HDAC1
SCHEMBL4643729 0.83 ALDH1A1 (0.84) ALDH1A1MAPTL3MBTL1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 US disclosed
CN-1921847-B Amino alcohol compound SANKYO CO 2010-06-16 CN disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 US disclosed
CN-1921847-A Amino alcohol compound SANKYO CO (JP) 2007-02-28 CN disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191468-A1 Amino alcohol compound ADH1A, ADH1C, BCAT1 ALDH1A1 62/4885MAPT 2680/4885L3MBTL1 417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.